PGCANA IIT IL 1 beta in pyoderma gangrenosum

Subsequent to identification of overexpressed interleukin 1 beta in biopsies of pyoderma gangrenosum, we performed a trial with the interleukin 1 beta inhibitor canakinumab.

Team

Alexander Navarini, Prof. Dr. med. Dr. sc.nat.
T. Maul, MD, NMID-Team
A. Kolios, MD, NMID-Team
M. Drach, MD univ.
T. Meyer, Leitung Studienkoordination
J. Püschel, Studienkoordination

Running since

1.1.2012

Finished on

1.1.2015

We Value Your Privacy!

We and our partners are using technologies like cookies and process personal data like the IP-address or browser information in order to analyze the website data. This helps us to improves your internet experience. We also use it in order to measure results or align our website content. Because we value your privacy, we are herewith asking for your permission to use these technologies. You can always change/withdraw your consent later.

Necessary Cookies

Analytics